BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28159673)

  • 1. RIPK1 binds to vitamin D receptor and decreases vitamin D-induced growth suppression.
    Quarni W; Lungchukiet P; Tse A; Wang P; Sun Y; Kasiappan R; Wu JY; Zhang X; Bai W
    J Steroid Biochem Mol Biol; 2017 Oct; 173():157-167. PubMed ID: 28159673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm.
    Trivedi T; Zheng Y; Fournier PGJ; Murthy S; John S; Schillo S; Dunstan CR; Mohammad KS; Zhou H; Seibel MJ; Guise TA
    Oncotarget; 2017 Apr; 8(16):26687-26701. PubMed ID: 28460457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun NH2-teminal kinase 1 interacts with vitamin D receptor and affects vitamin D-mediated inhibition of cancer cell proliferation.
    Bi X; Shi Q; Zhang H; Bao Y; Hu D; Pohl N; Fang W; Dong H; Xia X; Fan D; Yang W
    J Steroid Biochem Mol Biol; 2016 Oct; 163():164-72. PubMed ID: 27174721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of epithelial ovarian cancer invasion into the omentum by 1α,25-dihydroxyvitamin D3 and its receptor.
    Lungchukiet P; Sun Y; Kasiappan R; Quarni W; Nicosia SV; Zhang X; Bai W
    J Steroid Biochem Mol Biol; 2015 Apr; 148():138-47. PubMed ID: 25448740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
    Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
    Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo.
    Verone-Boyle AR; Shoemaker S; Attwood K; Morrison CD; Makowski AJ; Battaglia S; Hershberger PA
    Oncotarget; 2016 Jan; 7(1):995-1013. PubMed ID: 26654942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel vitamin D receptor interacting proteins that modulate 1,25-dihydroxyvitamin D3 signaling.
    Marshall PA; Hernandez Z; Kaneko I; Widener T; Tabacaru C; Aguayo I; Jurutka PW
    J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):147-59. PubMed ID: 22626544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential response of lung cancer cell lines to vitamin D derivatives depending on EGFR, KRAS, p53 mutation status and VDR polymorphism.
    Maj E; Trynda J; Maj B; Gębura K; Bogunia-Kubik K; Chodyński M; Kutner A; Wietrzyk J
    J Steroid Biochem Mol Biol; 2019 Oct; 193():105431. PubMed ID: 31326626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
    Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
    Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
    Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
    J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutively active RAS signaling reduces 1,25 dihydroxyvitamin D-mediated gene transcription in intestinal epithelial cells by reducing vitamin D receptor expression.
    DeSmet ML; Fleet JC
    J Steroid Biochem Mol Biol; 2017 Oct; 173():194-201. PubMed ID: 28104492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cellular environment on the selective activation of the vitamin D receptor by 1alpha,25-dihydroxyvitamin D3 and its analog 1alpha-fluoro-16-ene-20-epi-23-ene-26,27-bishomo-25-hydroxyvitamin D3 (Ro-26-9228).
    Ismail A; Nguyen CV; Ahene A; Fleet JC; Uskokovic MR; Peleg S
    Mol Endocrinol; 2004 Apr; 18(4):874-87. PubMed ID: 14726489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action.
    Nezbedova P; Brtko J
    Endocr Regul; 2004 Mar; 38(1):29-38. PubMed ID: 15147236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of 1,25D3-MARRS (membrane associated, rapid response steroid-binding), a novel vitamin D receptor, in growth inhibition of breast cancer cells.
    Richard CL; Farach-Carson MC; Rohe B; Nemere I; Meckling KA
    Exp Cell Res; 2010 Mar; 316(5):695-703. PubMed ID: 20036234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.
    Wietzke JA; Ward EC; Schneider J; Welsh J
    Mol Cell Endocrinol; 2005 Jan; 230(1-2):59-68. PubMed ID: 15664452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,25-Dihydroxyvitamin D
    Kjalarsdottir L; Tersey SA; Vishwanath M; Chuang JC; Posner BA; Mirmira RG; Repa JJ
    J Steroid Biochem Mol Biol; 2019 Jan; 185():17-26. PubMed ID: 30071248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D Signaling Modulators in Cancer Therapy.
    Luo W; Johnson CS; Trump DL
    Vitam Horm; 2016; 100():433-72. PubMed ID: 26827962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D-induced up-regulation of human keratinocyte cathelicidin anti-microbial peptide expression involves retinoid X receptor α.
    Svensson D; Nebel D; Voss U; Ekblad E; Nilsson BO
    Cell Tissue Res; 2016 Nov; 366(2):353-362. PubMed ID: 27357804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor.
    Liu YY; Nguyen C; Peleg S
    Mol Endocrinol; 2000 Nov; 14(11):1776-87. PubMed ID: 11075811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.